Immunic, Inc. — Key Metrics
2 years of history · ending 2014-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Working Capital Analysis
52-Week Range
ROIC vs WACC
EPS (Diluted)
—
Book Value Per Share
—
Free Cash Flow Per Share
—
Cash Per Share
—
OCF Per Share
—
Return on Equity
-180.2%
Return on Assets
-61.6%
Return on Invested Capital
-150.3%
Current Ratio
10.20
Quick Ratio
10.20
Working Capital
$95M
Net Current Asset Value
$105M
Invested Capital
$98M
OCF / Net Income
0.86
FCF / Net Income
0.89
Accruals Ratio (Sloan)
-6.3%
Net Debt
$-102M
Net Debt / EBITDA
2.08
Interest Coverage
—
Cash Coverage
—
Capex Coverage
-28.97
Tangible Common Equity
$98M
TCE / Total Assets
90.3%
Goodwill / Total Assets
—
NOPAT
$-40M
Cash ROIC
-159.7%
Capex / D&A
1.30
Reinvestment Rate
-0.6%
Book Value 5Y CAGR
—
Stock Price (FY-end)
$10K
Market Cap
—
P/B Ratio
—
P/TB Ratio
—
Enterprise Value
—
FCF Yield
—
Shareholder Yield
—
R&D Yield
—
Capex Yield
—
Shares Variation (YoY)
—
Beta (5Y)
1.34
Cost of Equity
11.2%
52W High
$13K
52W Low
$4K
Trailing Return 1Y
—
Trailing Return 5Y
—
F-Score (Piotroski)
3.00
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.